Background: Cardiac fibrosis is a key antecedent to many types of cardiac dysfunction including heart failure. Physiological factors leading to cardiac fibrosis have been recognized for decades. However, the specific cellular and molecular mediators that drive cardiac fibrosis, and the relative impact of disparate cell populations on cardiac fibrosis, remain unclear.
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Introduction
The mammalian heart is composed of a complex and heterogeneous network of cells. While cardiomyocytes (CMs)-the contractile cells of the heart-constitute the majority of cardiac cell mass, non-myocytes far outnumber CMs [1] . Little is known about how the individual cellular components of the heart operate together as an integrated unit, how this cellular ecosystem is altered in the context of physiological stress, and how disparate cell populations may contribute to the functional decline that accompanies cardiac injury, aging, hypertension or obesity. Moreover, while biological sex is recognized as an important variable in cardiovascular homeostasis and disease [2] , little is known about how biological sex affects gene expression in disparate cardiac cell populations following chronic tissue stress.
To study the cardiac cellulome-the network of cells that forms the heart-in the context of chronic stress, we used an Angiotensin II (AngII) cardiac hypertrophy model and applied a novel method for simultaneous transcriptional profiling of single CM nuclei and non-myocyte cells. Our study revealed shared and distinct cellular pathways driving AngII-induced cardiac fibrosis. Fibrosis developed in a manner independent of myofibroblasts, a cell type conventionally recognized as a key mediator of cardiac fibrosis. This study also documents extensive sexual dimorphism in the gene expression profiles of cardiac cells, underscoring how biological sex influences responses to tissue stress. This work provides a valuable resource for cardiac cell biology research and offers important insights into the orchestrated cellular and molecular mechanisms that drive cardiac fibrosis and heart failure.
Results
Previous large-scale single cell transcriptomic studies exploring cardiac cellular diversity have failed to profile key cardiac cell populations including CMs [3] [4] [5] [6] due to a reliance on dropletbased sequencing approaches that are incompatible with large cell isolation. Moreover, extraction of CMs from rodent hearts typically requires retro-aortic perfusion with proteases to liberate cells from the extracellular matrix; this is a relatively time-consuming process that has limited applicability for cell preparation in transcriptomic studies [7] .
To overcome these limitations, we developed a novel experimental framework to isolate and prepare all cardiac cells for single cell RNA-seq (scRNA-seq; Figure 1A ). The goal of this approach was to profile all cardiac cell types with maximum possible throughput and accuracy, subject to limitations based on biological characteristics and the specifications of current scRNA-seq instrumentation. Based on recent innovations in CM isolation [8] , we developed a perfusion-based tissue dissociation protocol that enables simultaneous isolation of cardiac cells from multiple hearts (see Methods). To address the challenge of CM size, CMs were denuded of their cell bodies to liberate nuclei for droplet-based transcriptional profiling. As proof of concept, both CM nuclei and non-myocyte nuclei were isolated independently and pooled for sequencing (Online Figure 1 ). Isolation of cells using this methodology yielded similar nonmyocyte cell proportions to protocols previously employed [4] although total cell yield and the number of extracted endothelial cells was lower (Online Figure 2 ). Although isolation of nuclei overcame critical limitations related to CM size, for all further experimentation the nonmyocyte fraction was preserved as whole cells to provide access to total cellular RNA and to allow control of input cell proportions for scRNA-seq by fluorescence-activated cell sorting using cell surface markers ( Figure 1A ).
Following isolation of both CM nuclei and non-myocyte cells, scRNA-seq was performed on a mixture of non-myocytes and myocytes from homeostatic female and male hearts. We limited the relative number of endothelial cells and CM nuclei to minimize oversampling of these abundant cell populations at the expense of resolving less frequent cell types. Following clustering of 7,474 cells ( Figure 1B ), examination of established marker genes and top cell population-enriched genes ( Figure 1C -D) revealed a wide array of cell types that were present in all samples (Online Figure 3 ). These include fibroblasts (Pdgfra, Col1a1), pericytes (Pdgfrb, Vtn), smooth muscle cells (SMCs; Acta2, Myh11), Schwann cells (Plp1, Kcna1), endothelial cells (Pecam, Ly6c1), macrophages (Fcgr1, Csf1r), and other immune cell populations 6 (granulocytes, B cells, T cells and NK cells). A subset of fibroblasts (Fibroblast-Wif1) showed distinct gene expression patterns including active Wnt signaling and specific expression of Wif1, in line with our previous report [4] and the findings of Farbehi et al [5] . Additional less well-characterized cell populations included CMs (Ttn, Myh6), epicardial cells (Msln, Upk3b), lymphatic endothelial cells (Lyve1, Cldn5) and endocardial cells (Npr3, Cytl1) ( Figure 1B-D) .
Cardiac tissue from mice at a relatively early stage of disease development (two weeks of chronic AngII administration) was analyzed to capture early cellular and molecular changes that lead to pathological remodeling of the heart (Figure 2A ). An increase in heart mass and fibrotic area was noted in both female and male mice treated with AngII, however, hemodynamic changes and functional impairment were principally restricted to male mice that had a reduction of ejection fraction (Online Figure 4 ), in line with trends in human populations [9] . Histological analyses of hypertrophic mouse hearts showed a greater cross-sectional area and higher levels of fibrosis in both female and male hearts ( Figure 2B -C). Together these observations describe the pathological remodeling of the heart with AngII-induced pathological hypertrophy in both female and male contexts.
To examine cellular and molecular changes that accompany induction of fibrosis, we performed scRNA-seq on isolated myocytes and non-myocytes in a total of 12 hearts from sham and AngII-treated mice. Combining these data with cells from the four homeostatic female and male hearts described above, we obtained a total of 29,615 cells and performed clustering to identify a diverse array of cardiac cell types and subtypes ( Figure 2D ).
Examination of cell abundances within this scRNA-seq dataset revealed several cell populations that changed in relative prevalence in response to AngII (Figure 2E -F). Most notably, two fibroblast subpopulations which were not present at an appreciable number in unstressed hearts ( Figure 2E -F; Online Figure 5 ) increased dramatically in hearts of mice treated with AngII and expressed high levels of periostin ( Figure 2E ). We refer to these cell populations as Fibroblast-Cilp and Fibroblast-Thbs4-reflecting markers that are highly expressed within these populations-with Fibroblast-Cilp being the largest cell population in this fibrosis dataset.
To determine whether subpopulations of fibroblasts, endothelial/endocardial cells or macrophages/dendritic-like cells (DLCs) change in abundance following AngII treatment, we further clustered these cell populations in isolation before examining relative abundances of any new clusters (Online Figure 6 ). Sub-clustering fibroblasts did not significantly fragment 7 fibroblast subpopulations further. In contrast, sub-clustering endothelial cells revealed two subclusters that decrease or increase in abundance following AngII treatment (Online Figure 6 ).
Moreover, sub-clustering divided dendritic-like cells to three subpopulations, with one decreasing significantly upon hypertrophy induction. Macrophages did not fragment further compared to original clusters (Online Figure 6 ).
The limited input of specific cell populations for scRNA-seq analysis might restrict the detection of shifts in abundances of certain cell populations. To examine cell composition using an orthogonal method, we performed flow cytometric analysis of control and AngII-treated mouse hearts (Online Figure 7) . Macrophages significantly increased in abundance in males, compared to controls. However, there was no significant increase in fibroblasts detected by flow cytometry (Online Figure 7 ), suggesting that Fibroblast-Cilp and Fibroblast-Thbs4 represent a cell state arising primarily from resident fibroblasts rather than infiltration or proliferation of cells. Indeed, single cell transcriptional profiling of cell cycle states [10] revealed no significant increase in proliferation of fibroblast populations or in other cell compartments in response to AngII (Online Figure 8 ).
AngII treatment induced gene expression changes in all cardiac cell populations ( Figure 3A ).
Most notably, fibroblast populations up-or downregulated the greatest numbers of genes, with macrophage and endothelial cell subsets also exhibiting high reactivity. Endothelial and smooth muscle cell sub-clusters (particularly endothelial1 and SMC1) and CMs exhibited highly asymmetrical patterns, with a predominance of either activating or repressive changes in gene expression ( Figure 3A ).
Examination of the top 10 upregulated genes for each cell type revealed several patterns relevant to hypertrophy ( Figure 3B ). Among the top genes upregulated upon AngII treatment were transcripts for Cilp, Comp, Crlf1, Postn, and Thbs4, some of which have been previously implicated in human heart failure [11] [12] [13] . Notably, these genes exhibit a subtle but significant increase in expression across almost all heart cell types under AngII treatment. Genes that were upregulated in clusters of cells or across a limited number of cell populations included Ms4a7
(macrophages) and Gm13889 (pericytes and SMCs). Upregulated genes highly restricted to one cell type included Ccl21a (lymphatic endothelial cells), and Nppb and Nppa (in CMs), which are well-established biomarkers of heart failure [14] . Gene ontology (GO) analysis of AngII-upregulated genes revealed that the top three GO terms in most cardiac cell types contribute to remodeling of the cardiac ECM ( Figure 3C ). 8 Of the top 10 downregulated genes, epicardial cells exhibited the greatest number of cellspecific downregulated genes (B4galt5, Cst9, and Has1; Online Figure 9A ) with others such as Spic1 (Mac1), Cd207 (DLCs), Ptpdc1 (Fibroblast 9), Thap8 (Mac1), Arhgap17 (NK cells), Letmd1 (NK cells), and Atp1a2 (T cells) restricted to single cell types (Online Figure 9A ).
Multiple genes related to ATP synthesis and mitochondrial activity (e.g. mt-Co2, mt-Nd4l)
were also downregulated, particularly in macrophages and endothelial cell populations (Online Figure 9A ). GO analysis of downregulated genes revealed multiple coherent gene programs induced by AngII (Online Figure 9B ), the most frequent of which were those associated with protein translation, particularly amongst fibroblasts, as well as pathways related to inflammation and infiltration of monocytes and other leukocytes.
Abundances of Fibroblast-Cilp and Fibroblast-Thbs4 changed most dramatically upon treatment with AngII ( Figure 2F ). To determine the impact of these cell populations on cardiac remodeling, we first compared differentially expressed genes between Fibroblast-Cilp and
Fibroblast-Thbs4 compared to all other control cells within this dataset, cardiac fibroblasts from control animals, and fibroblasts from AngII-treated animals (Figures 4A-C, respectively).
Features common to basic fibroblast biology defined Fibroblast-Cilp and Fibroblast-Thbs4
when compared to all cardiac cells (e.g. collagen and ECM organization). When compared to all fibroblasts from control animals or AngII-treated cohorts ( Figure 4B and C, respectively), collagen remodeling genes were the primary distinguishing features of Fibroblast-Cilp and Fibroblast-Thbs4. Comparison of Fibroblast-Cilp and Fibroblast-Thbs4 also showed higher levels of ECM remodeling genes in Fibroblast-Cilp compared to Fibroblast-Thbs4 ( Figure 4D ).
Indeed, examination of total transcripts corresponding to ECM remodeling genes suggests that
Fibroblast-Cilp and Fibroblast-Thbs4 are key contributors to ECM remodeling, with the Fibroblast-Cilp population contributing greater summed transcript abundance than all other cell populations in AngII-treated mice (Online Figure 10 ).
Fibroblast-Cilp and Fibroblast-Thbs4 were also distinguished by the upregulation of genes such as Thbs4, Fmod, Cthrc1 and Cilp2 ( Figure 4E ). No genes were uniquely and highly expressed in Fibroblast-Cilp that were not also expressed in Fibroblast-Thbs4. THBS4 + cells in AngIItreated hearts ( Figure 4F ) were aggregated within foci and could also be identified as discrete cells ( Figure 4F , i and ii, respectively; Online video 1). An absence of THBS4 + cells surrounding perivascular fibrotic lesions ( Figure 4F , iii), suggested Fibroblast-Thbs4 are principally involved in interstitial fibrosis. Finally, in accordance with transcriptomic analyses, we confirmed that neither Fibroblast-Cilp nor Fibroblast-Thbs4 correspond to ACTA2 + myofibroblasts ( Figure 4G and H) using mice from two independent mouse colonies. These findings suggest that Fibroblast-Cilp and Fibroblast-Thbs4 may be transcriptionally similar to the matrifibrocyte, a specialized fibroblast state found in the mature scar after MI [15] . While Fibroblast-Cilp/Thbs4 had some expression of the matrifibrocyte markers Comp, Sfrp2, and
Wisp2 [6, 15] , these genes are less specific for Fibroblast-Cilp and Fibroblast-Thbs4 than Cilp, Ddah1, or Thbs4 (Online Figure 11 ).
To explore the origins of Fibroblast-Cilp and Fibroblast-Thbs4, we examined dynamic patterns of transcriptional activation and repression in detail in all fibroblasts using RNA velocity [16] , as implemented in scVelo [17] . This analysis suggested that the Fibroblast-Thbs4 population predominantly arises from Fibroblast-Cilp, while Fibroblast-Cilp has broader origins from Fibro5 and Fibro6 ( Figure 5A ). Use of two independent pseudotime-based methods yielded results that were also concordant with these conclusions (Online Figure 12 ). Some transcripts expressed in both Fibroblast-Cilp and Fibroblast-Thbs4, such as Cilp and Postn, showed gradients in velocity across Fibroblast-Cilp into Fibroblast-Thbs4 ( Figure 5B -C), suggesting that Fibroblast-Thbs4 cells represent a cell state characterized by transcriptional activation of a unique set of genes. Certain genes that were not clearly fibroblast subpopulation-specific yet appeared to play a role in AngII-induced remodeling included Svep1, the second-ranked gene differing in velocity between Fibroblast-Cilp/Fibroblast-Thbs4 and the remaining fibroblast subpopulations (the top-ranked gene, Adcy7, is likely involved in cross-talk with AngII signaling pathways in cardiac fibroblasts [18] ). Figure 5D demonstrates that Svep1 is strongly activated in Fibroblast-Cilp/Fibroblast-Thbs4, consistent with the recognized role of Svep1 as a GWAS-implicated hypertension risk gene [19] . Notably, steady-state gene expression levels alone did not clearly link Svep1 expression to cell populations specific to AngII-treatment ( Figure 5E ).
To determine the impact of AngII treatment on cardiac intercellular signaling, we mapped ligands and cognate receptors expressed by various cell populations ( Figure 6 ). As previously reported [4] , a similar analysis revealed extensive intercellular communication in homeostatic hearts. Signaling by fibroblasts, along with macrophages, represented key features of the interstitial cardiac niche at homeostasis ( Figure 6A ; Online Figure 13 ). DLCs, epicardial cells and endocardial cells were also significant populations forming extensive potential signaling networks within a diverse array of cell types ( Figure 6A , Online Figure 13 ). In contrast, consistent with previous analyzes [4] patrolling cell populations-granulocytes, NK cells and lymphocytes-were amongst the least interactive cell populations. Few interactions observed for CMs may be attributable to a lower number of genes and reads in this cell population due to transcriptional profiling of nuclei rather than whole cells.
Examination of factors essential for supporting specific cell populations points to important trophic intercellular interactions ( Figure 6B ). In addition to previously reported expression patterns for Igf1, Il34, Ngf and Ntf3 ( Figure 6B ; [4] ), epicardial cells were identified as the most highly enriched for Csf1 transcripts, required for macrophage vitality, while CMs were the primary producers of Vegfa that supports endothelial cell growth ( Figure 6B ). Although the role of epicardial cells in supporting macrophage trafficking in fetal development has been previously established [20] , this result suggests that epicardial cells are the most macrophagetrophic cell population by Csf1/Csf1r signaling ( Figure 6B ). Indeed, the spatial distribution of macrophage subsets relative to the epicardium is distinct ( Figure 6C ), and further accentuated in older animals [21] , underscoring the epicardium and sub-epicardial space as a macrophagetrophic environment in the adult heart.
Cell-cell signaling in response to AngII-induced hypertrophy was increased in all cell types studied, with fibroblasts increasing the greatest number of connections ( Figure 6D ). GO enrichment analysis of upregulated connections between cell types revealed that the most frequently increased ligands involved cellular response to amino acid stimulus and collagen fibril organization ( Figure 6E ); upregulated receptors included those interacting with ECM ( Figure 6F ). Notably, ligands involved in angiogenesis were upregulated in multiple cell types, while endothelial cells upregulated cognate receptors ( Figure 6F ). Together these analyzes indicate a concerted effort by multiple cell types in the cardiac cellulome to alter the cardiac niche and drive ECM remodeling.
Conversely, GO terms related to downregulated ligands showed a clear dampening of inflammation in the cardiac microenvironment (Online Figure 14) , with almost all enriched GO terms related to inflammation or leukocytes/monocyte trafficking. Intriguingly, other GO terms enriched within downregulated ligands and receptors were associated with angiogenesis, suggesting the up-and downregulation of receptors within endothelial cells may reflect changes in cellular phenotype and shifts in sensitivity to angiotrophic cues.
Analysis of hemodynamic and cardiac functional parameters, as well as quantification of tissue fibrosis, suggested extensive sexual dimorphism in the development of pathological remodeling in response to AngII. Many upregulated genes were modulated by estradiol (Online Figure 15 ). Sexually dimorphic differences in cardiac cellularity after AngII treatment were detected (Online Figure 7 ) including development of fibrosis in specific anatomical loci ( Figure   7A ).
To explore sex-specific gene expression patterns within specific populations of the cardiac cellulome, we isolated female and male cells from control and AngII-treated groups based on the expression of genes expected to differ between sexes (chromosome X and Y genes outside of the pseudoautosomal region; Figure 7B ; Online Figure 16 ). Comparison of proportions of female and male cell populations in control and AngII-treated hearts revealed no differences in cell abundance except within the Fibroblast-Thbs4 population, which was approximately twofold higher abundance of these cells in females compared to males ( Figure 7C ). and Fibroblast-Cilp of AngII-treated mice ( Figure 7D -E). This is in line with the high enrichment of sex hormone receptors expressed by these cells (Online Figure 17 ). Consistent with a positive relationship between cell number and power to detect sexually dimorphic gene expression, we observed a slight yet statistically significant correlation between cell population size and the number of sexually dimorphic genes identified (Online Figure 18 ). Sexual dimorphism in expression of genes upregulated following AngII treatment ( Figure 7E -F, Online Figure 19 ) were detected in fibroblast populations (with the exception of Fibroblast-Wif1 and Fibroblast-Thbs4), with very few genes differentially regulated in other cell types.
( Figure 7E ). Very few dimorphisms in expression were identified amongst genes downregulated following cardiac fibrosis (Online Figure 20 ). Examination of genes with 2fold or greater difference between sexes in cells of control hearts revealed a heterogeneous collection of genes (Online Figure 21A ). These included genes encoding proteins such as GNGT2, CAMLG, TDP1, and NEK7 that have been previously identified as sexually dimorphic in human heart failure [22] . GO enrichment analysis of sexually dimorphic genes in control hearts showed an enrichment of genes corresponding to antigen processing in multiple female cell populations and protein folding, stress and angiogenesis in multiple male cell types (Online Figure 21B ). Consistent with sexually dimorphic regulation of the endothelium, flow cytometric analysis of endothelial cells showed greater numbers of endothelial cells in male mouse hearts (Online Figure 22 ). Genes such as Vegfa were upregulated in male (but not female) CMs and Fibroblast-Thbs4 populations from AngII-treated mice, further suggesting dimorphic angiogenic stimulation in females and males ( Figure 7E ). Amongst genes upregulated or downregulated in either sex (Online Figure 19 ), female hearts had an enrichment of ECM remodeling genes amongst the upregulated genes in Fibro6 and Fibroblast-Cilp, whereas males showed upregulation of genes involved in protein folding or responses to endoplasmic reticulum stress ( Figure 7E ). We also observed upregulation of ECM-organizing genes in male Fibro6 cells that were distinct from those upregulated in female Fibro6 or Fibroblast-Cilp populations, underscoring a potential difference in the quality of ECM generated in the two sexes upon tissue stress. GO enrichment analysis revealed no coherent biological themes shared among downregulated genes, principally in fibroblasts, whose expression was sexually dimorphic.
To determine whether Fibroblast-Cilp and Fibroblast-Thbs4 populations-those that emerge following induction of cardiac stress-are also present in the context of human pathological remodeling, we analyzed bulk cardiac RNA-seq data from 85 female and 172 male humans between the ages of 40 and 69 profiled by the Genotype-Tissue Expression (GTEx) Project. To segregate humans without and with putative hypertrophy NPPB expression was examined; this gene encodes the preprohormone preproBNP from which the cardiac hypertrophy biomarker B-type natriuretic peptide is derived [23] . Samples with the highest (top 20%) NPPB expression (without regard to age or sex) were classified as putatively hypertrophic (Online derived Il34 are both growth factors that support macrophages which we previously detected in the heart [4] , however, the current analysis found that epicardial cells are the most macrophage-trophic cardiac cell population as a result of their high production of Csf1.
Moreover, we identified distinct spatial distributions of macrophage subsets at the epicardium, suggesting additional unidentified regulation of macrophage positioning and/or trafficking.
These results further support the important role of epicardial cells in macrophage homeostasis, in accordance with previous studies demonstrating the role of the epicardium in macrophage colonization of the heart [20] . Also notable was the identification of CMs as the principal producers of Vegfa, which is a dominant endothelial and angiogenesis growth factor. While we have not examined the precise isoforms of Vegfa expressed by cardiac cells [25] , our analysis indicates that the cell type perhaps most dependent on tissue perfusion is the key driver of vascular innervation of the heart.
Examination of ligand genes upregulated following induction of hypertrophy revealed the entire cardiac cellular niche is altered to support ECM remodeling and angiogenesis. This corresponded with upregulation of receptor genes mediating cell adhesion in a wide variety of cells, whereas angiogenesis-related receptors were upregulated in endothelial cells. GO enrichment analysis of all genes upregulated following induction of fibrosis indicated that a primary response of most cell types is the activation of genes involved in ECM remodeling.
However, Fibroblast-Cilp and Fibroblast-Thbs4, which principally emerge following cardiac stress, appear to be the most fibrogenic cell populations based on expression of transcripts related to ECM remodeling GO terms. Their fibrogenic phenotype is further underscored when compared to other fibroblast populations from AngII-treated mice that extensively activate ECM remodeling and collagen genes. are key monocyte chemoattractants. Although AngII infusion caused an increase in macrophage abundance using flow cytometry, this was not accompanied by significant increases in pro-inflammatory mediators. This suggests that the cardiac cellulome functions to dampen inflammation in order to regulate inflammatory responses. Further, we found mitochondrial bioenergetics are subdued in many cell types, particularly in endothelial cells and macrophages, in accordance with the association between mitochondrial activity and heart failure.
The current study also identified numerous cell type-specific genes that were robustly upregulated in hypertrophy (such as Rapsn in SMCs or Fastkd1 in epicardial cells) with unknown implications for cardiac pathology. Similar relationships were observed amongst downregulated genes (for example Thap8 in macrophages or Has1 in the epicardium). These genes constitute appealing subjects for further research to explore their expression in further detail, and to their validity as potential therapeutic targets.
Analysis of the abundance of Fibroblast-Cilp and Fibroblast-Thbs4 cell populations suggest sex differences in cellular abundance ( Figure 7C ), which is of particular interest in light of known sexual dimorphisms in cardiac stiffness [30] . Indeed, analysis of cardiac fibrosis in mice treated with AngII revealed differences in fibrotic area in addition to the distribution of fibrotic loci.
Females were characterized by less fibrosis in the left ventricle wall and the absence of fibrosis in the right ventricle walls, as well as less perivascular fibrosis. In contrast, greater fibrosis accumulated in the female interventricular septum compared to males, although a functional decline was only observed in males.
In both the non-stressed and stressed contexts, sexual dimorphisms were observed in cardiac gene expression across almost all cell types, principally present in fibroblasts that are the major sex hormone-receptor expressing cells in the heart. In the context of cardiac fibrosis, female and male cardiac fibroblasts regulated distinct sets of genes that are associated with ECM remodeling, suggesting cardiac ECM quality is biologically distinct in the two sexes.
A key sexually dimorphic characteristic is the upregulation of genes related to unfolded protein responses (UPR) and endoplasmic reticulum (ER) stress in multiple male cell populations.
Indeed, UPR may at least partly explain two sexually dimorphic features in this fibrosis dataset.
First, an increase in UPR may contribute to the increased fibrosis observed in male hearts ( Figure 7A ). ER stress is observed in multiple models of tissue fibrosis including multiple models of maladaptive cardiac remodeling [31] and attenuation of UPR inhibits fibrosis [32] [33] [34] . Second, UPR may contribute to downregulation of translation-related genes in males. UPR may elicit this by multiple means including IRE1-mediated translational control of the transcription factor Xbp1, and regulation of multiple genes including eukaryotic initiation factor (Eif) genes and others involved in protein translation [31] . Incidentally, Xbp1 is upregulated in multiple male cardiac cell types, and is associated with tissue fibrosis in the heart and elsewhere [35, 36] .
In addition to the link between protein translation and UPR, translation is also supported by estrogens in several species and in both neoplastic and non-neoplastic tissues [37] [38] [39] . In tumor cells, inhibition of estrogen receptor α induces UPR [37] . Moreover, estrogen has been recently shown to regulate Eif genes to promote protein synthesis [40] . Many Eif genes upregulated after AngII infusion across multiple female cell populations in addition to many ribosomal protein genes. Together, these observations suggest female cells are better primed for protein synthesis as well as avoidance of tissue fibrosis and maladaptive remodeling.
Conversely, the enrichment of genes implicated in angiogenesis was observed in multiple male cardiac cell populations including Fibro 2, Fibro 6, Fibroblast-Cilp and Fibroblast-Thbs4 from non-stressed mice. Accordingly, increased numbers of endothelial cells were found in male hearts compared to females. In addition, significantly higher levels of Vegfa expression was detected in male CMs and Fibroblast-Thbs4 cells after fibrosis induction. While estrogen has been reported to enhance angiogenesis in a range of contexts [41] , more recent research suggests that loss of estrogen receptor promotes angiogenesis [42] . Additionally, testosterone induces angiogenesis in a sex-dependent manner, further underscoring the importance of the hormonal milieu [43] . Finally, UPR is also strongly linked to upregulation of pro-angiogenic genes [44] , resulting in a more pro-angiogenic environment in male hearts.
The findings of this study offer unique insights into the multifaceted mechanisms driving maladaptive remodeling of the heart, including important components of this process that are sexually dimorphic. They also highlight the utility of the single cell transcriptomics data and the overall approach presented in this study for exploring the cardiac cellulome and its changes in the context of chronic tissue stress. Further analysis of cardiac cell networks, with integration of data from different developmental and disease states, time points, and genetic backgrounds, will further advance our understanding of cardiac cellularity in health and disease.
METHODS
Animals
All experimental procedures performed on C57BL/6J mouse strain following protocols approved by Jackson Laboratory Animal Research ethics committee. Angiotensin II (1.5 or 1.44 mg/kg/day) or saline infusion was performed on 8-week-old female and male mice over a period of two weeks before subsequent analyses.
Cardiac single-cell preparation, sequencing and analysis.
Cardiac single-cell and single-nucleus suspensions of non-myocytes and cardiomyocyte nuclei, respectively, were prepared using a modified from Ackers-Johnson et al., 2016 [8] before subsequent processing as outlined in Figure 1A . Single-cell RNA-seq was performed using the 10X Genomics Chromium Single Cell 3' Library and Gel bead Kit v2.
For additional information see Online Materials and Methods.
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Online Figure 11. Markers of matrifibrocytes and Fibroblast-Cilp and Fibroblast-Thbs4.
Figures show FItSNE projections for cardiac cell populations (as shown in
Online Figure 17. Sex hormone receptors in cardiac cells from mice with and without
AngII treatment.
Violin plots generated with Seurat showing the expression of various hormone receptors across
all cardiac cell types. Androgen receptor expression (Ar) is greatest in cardiac fibroblasts.
Estrogen receptor α and estrogen receptor β (Esr1, Esr2, respectively) are both lowly expressed, but most highly detected in cardiac fibroblasts. The membrane bound G proteincoupled estrogen receptor 1 (Gper1) is also lowly expressed, but greatest in endothelial cells and pericytes.
Online Figure 18 . Relationship between number of sexually dimorphic genes discovered and cell population size.
Top panel summarizes the relationship in cardiac cell populations from control animals.
Bottom panel summarizes the relationship in cardiac cell populations from AngII-treated animals.
Online Figure 19 . Strategy for determining sexually dimorphic genes regulation following AngII treatment (related to figure 7D-F) .
For each cell population, female and male cells were considered in isolation and genes upregulated or downregulated following AngII treatment determined. For dimorphisms in upregulated genes (results shown Figure 7D -F), a list of genes upregulated in either females or males was generated and sexual dimorphisms in gene expression was examined. For dimorphisms in downregulated genes (results shown Online Figure 20) , a list of genes downregulated in either sex was generated and dimorphism in expression was again examined.
Online Figure 20 . Sexual dimorphism in gene expression amongst genes that are downregulated in cardiac cells following AngII treatment.
The number of genes which are downregulated in response to AngII as well as exhibiting sexually dimorphic gene expression, presented for each cardiac cell type. In this context upregulated refers to a gene that is greater in either sex, but overall remains lower after AngII.
Strategy to determine sexually dimorphisms is outlined in Online Figure 19 . 
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fibroblasts-Wif1 Figure 5 shows results for all cell populations. [45] . Individual female and male mice are indicated by red and blue dots, respectively. Y-axis shows cell abundance and regression lines derived separately from female and male samples are shown in red and blue, respectively. D) Number of sexually dimorphic genes in cardiac cell types from hearts without (control) fibrosis induction. Number of genes at significantly higher levels in females and males is indicated for each cell type by red and blue circles, respectively. E) Sexually dimorphic gene expression in genes upregulated cardiac cells following AngII-treatment. See Methods and Online Figure 19 for details. A summary of GO terms of genes upregulated in female cells (red text) or male cells (blue text) is shown in the table below. Fibroblast-Cilp and Fibroblast-Thbs4 are not shown as this analysis was restricted to cells present during both homeostasis and AngII-treatment. F) Dot plot summarizing the expression of genes changing in a sexually dimorphic manner in response to AngII. Plot shows genes that are upregulated after AngII treatment and differentially expressed between corresponding female and male cells (p <0.001). Dot color and size are proportional to the relative expression and relative proportion of cells expressing compared between females and males, respectively.
